Understanding COVID-19 Vaccination Trends in Expectant Mothers

A recent national study in France has shed light on COVID-19 vaccination rates among pregnant women, revealing critically important insights into vaccination timing, socio-economic factors, adn potential disparities compared to the general population. The research underscores the critical need for targeted interventions to improve vaccination coverage in this vulnerable group.

Key Findings: Vaccination Coverage and Timing

The study, leveraging data from the epi-Meres register encompassing over 1.2 million births between April 2021 and December 2022, found that 52% of pregnant women received at least one dose of a COVID-19 vaccine. Of those vaccinated, 62.1% received their first dose before conception, while 8.2%, 20.9%, and 8.8% were vaccinated during the first, second, and third trimesters, respectively.

Comparing Vaccination Rates: Pregnant Women vs.general Population

Initially, vaccination rates among pregnant women lagged behind those of the general female population. However, the study indicates that these rates converged around June 2022, reflecting a roughly six-month delay. This convergence suggests a catch-up in vaccination efforts, but also highlights the initial vulnerability of pregnant women during the pandemic’s peak.

Socio-Economic Disparities and Vaccination Status

The research identified meaningful socio-economic factors influencing vaccination rates. Younger women and those from socially disadvantaged backgrounds were less likely to be vaccinated. This finding aligns with broader trends observed globally, where access to healthcare and vaccine hesitancy frequently enough correlate with socio-economic status. For example, a recent study by the CDC in the United States found similar disparities, with lower vaccination rates among minority and low-income pregnant women.

Socio-economic status and the level of prenatal care were strongly associated with a low vaccination rate.

Prenatal Care and Vaccination Uptake

The study also revealed a correlation between prenatal care and vaccination status. Women who were less likely to be vaccinated tended to have fewer ultrasounds (Adjusted Odds Ratio (AOR), 0.71 [0.70-0.73]) and were less likely to take folic acid (AOR, 0.73 [0.72-0.74]). Furthermore, women in their third pregnancy were also less likely to be vaccinated (AOR, 1.21 [1.19-1.22]). These findings suggest that access to and engagement with prenatal care services play a crucial role in promoting vaccination.

Comorbidities and Vaccination Decisions

Interestingly, women with pre-existing comorbidities such as obesity, diabetes, hypertension, use of antidepressants, or chronic respiratory disease were *more* likely to be vaccinated (AOR between 0.69 and 0.89). This suggests that awareness of increased risk due to underlying health conditions may have motivated vaccination in this subgroup.

Implications and Future Directions

The French study underscores the importance of targeted interventions to improve COVID-19 vaccination rates among pregnant women,particularly those from socially disadvantaged backgrounds and those with limited access to prenatal care. Public health campaigns should address vaccine hesitancy, improve access to vaccination services, and emphasize the safety and efficacy of COVID-19 vaccines during pregnancy. Political adjustments and resource allocation are needed to ensure equitable access to vaccination for all segments of this population.

As of early 2025, global health organizations like the World Health Organization (WHO) continue to recommend COVID-19 vaccination for pregnant women, citing the significant risks associated with COVID-19 infection during pregnancy, including increased risk of severe illness, preterm birth, and other adverse outcomes.